Skip to main content
Log in

Alvimopan reduces costs in radical cystectomy for bladder cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Huang JT, et al. Alvimopan is Associated with a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy. Urology : 5 Apr 2020. Available from: URL: http://doi.org/10.1016/j.urology.2020.01.049

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alvimopan reduces costs in radical cystectomy for bladder cancer. PharmacoEcon Outcomes News 851, 3 (2020). https://doi.org/10.1007/s40274-020-6726-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6726-4

Navigation